FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q47561895> ?p ?o ?g. }

• Q47561895 description "2017 nî lūn-bûn" @default.
• Q47561895 description "2017年の論文" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年学术文章" @default.
• Q47561895 description "2017年學術文章" @default.
• Q47561895 description "2017年學術文章" @default.
• Q47561895 description "2017年學術文章" @default.
• Q47561895 description "2017年學術文章" @default.
• Q47561895 description "2017年學術文章" @default.
• Q47561895 description "2017년 논문" @default.
• Q47561895 description "article científic" @default.
• Q47561895 description "article scientific" @default.
• Q47561895 description "article scientifique" @default.
• Q47561895 description "articol științific" @default.
• Q47561895 description "articolo scientifico" @default.
• Q47561895 description "artigo científico" @default.
• Q47561895 description "artigo científico" @default.
• Q47561895 description "artigo científico" @default.
• Q47561895 description "artikel ilmiah" @default.
• Q47561895 description "artikull shkencor" @default.
• Q47561895 description "artikulong pang-agham" @default.
• Q47561895 description "artykuł naukowy" @default.
• Q47561895 description "artículo científico publicado en 2017" @default.
• Q47561895 description "artículu científicu" @default.
• Q47561895 description "bilimsel makale" @default.
• Q47561895 description "bài báo khoa học" @default.
• Q47561895 description "naučni članak" @default.
• Q47561895 description "scienca artikolo" @default.
• Q47561895 description "scientific article published on 27 December 2017" @default.
• Q47561895 description "scientific article published on 27 December 2017" @default.
• Q47561895 description "scientific article published on 27 December 2017" @default.
• Q47561895 description "teaduslik artikkel" @default.
• Q47561895 description "tieteellinen artikkeli" @default.
• Q47561895 description "tudományos cikk" @default.
• Q47561895 description "vedecký článok" @default.
• Q47561895 description "vetenskaplig artikel" @default.
• Q47561895 description "videnskabelig artikel" @default.
• Q47561895 description "vitenskapelig artikkel" @default.
• Q47561895 description "vitskapeleg artikkel" @default.
• Q47561895 description "vědecký článek" @default.
• Q47561895 description "wetenschappelijk artikel" @default.
• Q47561895 description "wissenschaftlicher Artikel" @default.
• Q47561895 description "επιστημονικό άρθρο" @default.
• Q47561895 description "мақолаи илмӣ" @default.
• Q47561895 description "наукова стаття, опублікована в грудні 2017" @default.
• Q47561895 description "научна статия" @default.
• Q47561895 description "научная статья" @default.
• Q47561895 description "научни чланак" @default.
• Q47561895 description "научни чланак" @default.
• Q47561895 description "מאמר מדעי" @default.
• Q47561895 description "مقالة علمية نشرت في 27 ديسمبر 2017" @default.
• Q47561895 description "২৭ ডিসেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q47561895 description "บทความทางวิทยาศาสตร์" @default.
• Q47561895 description "სამეცნიერო სტატია" @default.
• Q47561895 name "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 name "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 type Item @default.
• Q47561895 label "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 label "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 prefLabel "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 prefLabel "Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study." @default.
• Q47561895 P1433 Q47561895-ADCBEE82-D88A-4DC6-8AE3-69C20AF3EF81 @default.
• Q47561895 P1476 Q47561895-CD60A549-7689-4077-B8E4-41496677BADD @default.
• Q47561895 P2093 Q47561895-058F6E74-B16C-4EFD-B03D-B4598BD56DF0 @default.
• Q47561895 P2093 Q47561895-179EDB8D-FFDD-4030-A728-1E6C0E714256 @default.
• Q47561895 P2093 Q47561895-72962C44-1709-416F-A68F-FC5D9E01781F @default.
• Q47561895 P2093 Q47561895-7B2D9FEF-19A0-496E-B0A3-5EB53A4CB406 @default.
• Q47561895 P2093 Q47561895-7B463402-B1EF-44CC-B9A2-309008EA153C @default.
• Q47561895 P2093 Q47561895-991E6B40-19AB-4B4F-B236-60B29450E185 @default.
• Q47561895 P2093 Q47561895-D9DE4FDD-3AB8-469E-81A7-366633024737 @default.
• Q47561895 P2860 Q47561895-6BB371BD-B3BF-48D8-BB64-94A2BC13DF39 @default.
• Q47561895 P2860 Q47561895-AB232F51-319B-454A-9BE7-A366DAF3EE15 @default.
• Q47561895 P304 Q47561895-CF6533EB-30D8-4FFA-9B2C-0FE094454115 @default.
• Q47561895 P31 Q47561895-B0EA0115-C041-46CA-BC81-E3E06140E705 @default.
• Q47561895 P356 Q47561895-B721340B-FBE3-4B0C-AB8A-09F7D8729078 @default.
• Q47561895 P433 Q47561895-FDF311C6-F0BC-4FA7-A70D-EBB0A3358EAD @default.
• Q47561895 P478 Q47561895-C3F10191-D607-47F1-BDFA-C53A73860EF2 @default.
• Q47561895 P50 Q47561895-35BAEC42-17F2-4C11-A729-A8B4C34EF8FA @default.
• Q47561895 P50 Q47561895-7867821F-E2FF-4005-97BE-6C613F3A5513 @default.
• Q47561895 P577 Q47561895-40FDA049-2F3A-4B84-BE4B-0D052B90E701 @default.
• Q47561895 P698 Q47561895-D8732979-058C-4751-9EFF-B668D82DD427 @default.
• Q47561895 P8608 Q47561895-3B00F8B0-11A9-46AC-93D7-EBF2FC536FA9 @default.
• Q47561895 P356 J.JTHO.2017.12.009 @default.
• Q47561895 P698 29288764 @default.
• Q47561895 P1433 Q2448056 @default.
• Q47561895 P1476 "Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study" @default.
• Q47561895 P2093 "Dale Shuster" @default.
• Q47561895 P2093 "Frances A Shepherd" @default.
• Q47561895 P2093 "Giorgio V Scagliotti" @default.
• Q47561895 P2093 "Jeffrey S Ross" @default.
• Q47561895 P2093 "Joachim von Pawel" @default.
• Q47561895 P2093 "Qiang Wang" @default.
• Q47561895 P2093 "Wallace Akerley" @default.
• Q47561895 P2860 Q27851406 @default.
• Q47561895 P2860 Q34307548 @default.
• Q47561895 P304 "849-854" @default.

• next